# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4703500 | F | Antibacterial activity against hospital-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-811 by CLSI method | Staphylococcus aureus | 12 | organism-based format | Scientific Literature | ||
2. | ALA4703501 | F | Antibacterial activity against community-acquired Methicillin -resistant Staphylococcus aureus ATCC BAA-1556 by CLSI method | Staphylococcus aureus | 12 | organism-based format | Scientific Literature | ||
3. | ALA4703502 | B | Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assay | Escherichia coli | 36 | protein complex format | Scientific Literature | ||
4. | ALA4703503 | B | Inhibition of Escherichia coli topoisomerase IV by measuring relaxation activity incubated for 30 mins by fluorescence based assay | Escherichia coli | 36 | assay format | Scientific Literature | ||
5. | ALA4703506 | F | Antibacterial activity against Escherichia coli ATCC 25922 by CLSI method | Escherichia coli | 37 | organism-based format | Scientific Literature | ||
6. | ALA4703507 | F | Antibacterial activity against Escherichia coli ATCC 25922 in presence of PAbetaN by CLSI method | Escherichia coli | 36 | organism-based format | Scientific Literature | ||
7. | ALA4703508 | F | Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI method | Staphylococcus aureus | 37 | organism-based format | Scientific Literature | ||
8. | ALA4703509 | F | Antibacterial activity against Enterococcus faecium ATCC 35667 by CLSI method | Enterococcus faecium | 12 | organism-based format | Scientific Literature | ||
9. | ALA4703510 | F | Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 51559 by CLSI method | Enterococcus faecium | 12 | organism-based format | Scientific Literature | ||
10. | ALA4703511 | F | Antibacterial activity against Enterococcus faecalis ATCC 29212 by CLSI method | Enterococcus faecalis | 12 | organism-based format | Scientific Literature | ||
11. | ALA4703512 | F | Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51575 by CLSI method | Enterococcus faecalis | 12 | organism-based format | Scientific Literature | ||
12. | ALA4703513 | F | Antibacterial activity against Streptococcus pneumoniae ATCC 49619 by CLSI method | Streptococcus pneumoniae | 12 | organism-based format | Scientific Literature | ||
13. | ALA4703514 | F | Antibacterial activity against Streptococcus anginosus ATCC 33397 by CLSI method | Streptococcus anginosus | 12 | assay format | Scientific Literature | ||
14. | ALA4703515 | F | Antibacterial activity against Haemophilus influenzae ATCC 43095 by CLSI method | Haemophilus influenzae | 12 | organism-based format | Scientific Literature | ||
15. | ALA4703516 | A | Inhibition of human topoisomerase 2alpha | Homo sapiens | 5 | single protein format | Scientific Literature | ||
16. | ALA4703517 | B | Inhibition of human ERG expressed in CHO cells by Q-patch clamp assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
17. | ALA4703518 | A | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 10 uM incubated for 48 hrs by CCK-8 assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
18. | ALA4703519 | A | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 50 uM incubated for 48 hrs by CCK-8 assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
19. | ALA4703520 | F | Antibacterial activity against Clostridioides difficile ATCC 700057 by CLSI method | Clostridioides difficile | 7 | organism-based format | Scientific Literature | ||
20. | ALA4703521 | F | Antibacterial activity against Peptostreptococcus anaerobius ATCC 27337 by CLSI method | Peptostreptococcus anaerobius | 7 | organism-based format | Scientific Literature |